AstraZeneca PLC
1516.50
27-يناير-25 07:32:00
15 متأخرة بدقائق
الأسهم
+5.50
+0.36%
نطاق اليوم
1511.00 - 1527.50
ISIN
N/A
المصدر
Cboe
-
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
29 مايو 2024 07:32:19 بحسب NASDAQ US Markets
-
AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance
27 مايو 2024 01:59:14 بحسب NASDAQ US Markets
-
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
24 مايو 2024 09:30:58 بحسب NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
23 مايو 2024 09:35:27 بحسب NetDania Notify
-
AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines
21 مايو 2024 02:02:29 بحسب NASDAQ US Markets
-
AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates
20 مايو 2024 01:42:36 بحسب NASDAQ US Markets
-
AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment
19 مايو 2024 21:05:22 بحسب NASDAQ US Markets
-
AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients
16 مايو 2024 02:51:29 بحسب NASDAQ US Markets
-
AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide
08 مايو 2024 04:10:43 بحسب NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 أبريل 2024 02:15:01 بحسب NetDania Notify
-
AstraZeneca: Enhertu Improved PFS In HR-positive, HER2-low Metastatic Breast Cancer
29 أبريل 2024 01:45:52 بحسب NASDAQ US Markets
-
AstraZeneca's Truqap Plus Faslodex Recommended For EU Approval By CHMP For Advanced Breast Cancer
29 أبريل 2024 01:45:52 بحسب NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 أبريل 2024 11:52:49 بحسب NASDAQ US Markets
-
25 أبريل 2024 10:30:48 بحسب NASDAQ US Markets
-
25 أبريل 2024 10:15:48 بحسب NASDAQ Stocks
-
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
25 أبريل 2024 02:16:35 بحسب NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 أبريل 2024 02:15:24 بحسب NetDania Notify
-
ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection
24 أبريل 2024 02:37:17 بحسب NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
05 أبريل 2024 21:16:14 بحسب NASDAQ US Markets
-
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
05 أبريل 2024 08:38:12 بحسب NASDAQ Stocks